Eledon 製藥公司
DE ˙ DB ˙ US28617K1016
€2.92 ↓ -0.04 (-1.35%)
2026-06-04
分享價格
SecurityDE:2TK / Eledon Pharmaceuticals, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership10,832 shares
Latest Disclosed Value $ 33,363
ProShare Advisors LLC reports 5.51% increase in ownership of 2TK / Eledon Pharmaceuticals, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 10,832 shares of Eledon Pharmaceuticals, Inc. (DE:2TK) valued at $24,914 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 10,266 shares of Eledon Pharmaceuticals, Inc.. This represents a change in shares of 5.51% during the quarter. The current value of the position is $31,629 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 10,832 566 5.51 33 120.00 0.0000
2026-02-06 2025-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 10,266 10,266 16 0.0000
2025-11-06 2025-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 0 -12,019 -100.00 0 -100.00
2025-08-07 2025-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 12,019 12,019 33 0.0001
2017-02-13 2016-12-31 13F TOKAI PHARMACEUTICALS COM 88907J107 0 -15,256 -100.00 0 -100.00
2016-11-10 2016-09-30 13F TOKAI PHARMACEUTICALS COM 88907J107 15,256 -2,804 -15.53 23 -77.00 0.0003
2016-08-12 2016-06-30 13F TOKAI PHARMACEUTICALS COM 88907J107 18,060 301 1.69 100 0.00 0.0013
2016-05-06 2016-03-31 13F TOKAI PHARMACEUTICALS COM 88907J107 17,759 -1,786 -9.14 100 -41.18 0.0014
2016-02-05 2015-12-31 13F TOKAI PHARMACEUTICALS COM 88907J107 19,545 19,545 170 0.0021
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.